2018 CLINICAL CONFERENCE at the National Ryan White Conference on HIV Care & TreatmentEvaluation: Monday, December 10, 2018 Question Title * 1. Please indicate your academic degree, license, or position. MD DO PA RN NP PharmD RPh Other (please specify) 2. Please rate each presentation that you attended. If you did not attend or the question is not applicable, leave blank or choose N/A. DAY 2: MONDAY, DECEMBER 10, 2018 Question Title * Peter Chin-Hong, MD: Infectious and Other Complications of Immunobiologic Agents Used by Individuals With HIV Infection Excellent Very Good Good Fair Poor N/A Content Content Excellent Content Very Good Content Good Content Fair Content Poor Content N/A Effectiveness of speaker's teaching methods Effectiveness of speaker's teaching methods Excellent Effectiveness of speaker's teaching methods Very Good Effectiveness of speaker's teaching methods Good Effectiveness of speaker's teaching methods Fair Effectiveness of speaker's teaching methods Poor Effectiveness of speaker's teaching methods N/A Value in fulfilling objectives for this presentation Value in fulfilling objectives for this presentation Excellent Value in fulfilling objectives for this presentation Very Good Value in fulfilling objectives for this presentation Good Value in fulfilling objectives for this presentation Fair Value in fulfilling objectives for this presentation Poor Value in fulfilling objectives for this presentation N/A Value to your practice/responsibility (if applicable) Value to your practice/responsibility (if applicable) Excellent Value to your practice/responsibility (if applicable) Very Good Value to your practice/responsibility (if applicable) Good Value to your practice/responsibility (if applicable) Fair Value to your practice/responsibility (if applicable) Poor Value to your practice/responsibility (if applicable) N/A Freedom from commercial bias or influence Freedom from commercial bias or influence Excellent Freedom from commercial bias or influence Very Good Freedom from commercial bias or influence Good Freedom from commercial bias or influence Fair Freedom from commercial bias or influence Poor Freedom from commercial bias or influence N/A Please comment: Question Title * Joseph J. Eron, Jr, MD: Investigational Approaches to Antiretroviral Therapy: New Strategies and Novel Agents Excellent Very Good Good Fair Poor N/A Content Content Excellent Content Very Good Content Good Content Fair Content Poor Content N/A Effectiveness of speaker's teaching methods Effectiveness of speaker's teaching methods Excellent Effectiveness of speaker's teaching methods Very Good Effectiveness of speaker's teaching methods Good Effectiveness of speaker's teaching methods Fair Effectiveness of speaker's teaching methods Poor Effectiveness of speaker's teaching methods N/A Value in fulfilling objectives for this presentation Value in fulfilling objectives for this presentation Excellent Value in fulfilling objectives for this presentation Very Good Value in fulfilling objectives for this presentation Good Value in fulfilling objectives for this presentation Fair Value in fulfilling objectives for this presentation Poor Value in fulfilling objectives for this presentation N/A Value to your practice/responsibility (if applicable) Value to your practice/responsibility (if applicable) Excellent Value to your practice/responsibility (if applicable) Very Good Value to your practice/responsibility (if applicable) Good Value to your practice/responsibility (if applicable) Fair Value to your practice/responsibility (if applicable) Poor Value to your practice/responsibility (if applicable) N/A Freedom from commercial bias or influence Freedom from commercial bias or influence Excellent Freedom from commercial bias or influence Very Good Freedom from commercial bias or influence Good Freedom from commercial bias or influence Fair Freedom from commercial bias or influence Poor Freedom from commercial bias or influence N/A Please comment: Question Title * David L. Thomas, MD, MPH: Elimination of Hepatitis C in Individuals With HIV Infection Excellent Very Good Good Fair Poor N/A Content Content Excellent Content Very Good Content Good Content Fair Content Poor Content N/A Effectiveness of speaker's teaching methods Effectiveness of speaker's teaching methods Excellent Effectiveness of speaker's teaching methods Very Good Effectiveness of speaker's teaching methods Good Effectiveness of speaker's teaching methods Fair Effectiveness of speaker's teaching methods Poor Effectiveness of speaker's teaching methods N/A Value in fulfilling objectives for this presentation Value in fulfilling objectives for this presentation Excellent Value in fulfilling objectives for this presentation Very Good Value in fulfilling objectives for this presentation Good Value in fulfilling objectives for this presentation Fair Value in fulfilling objectives for this presentation Poor Value in fulfilling objectives for this presentation N/A Value to your practice/responsibility (if applicable) Value to your practice/responsibility (if applicable) Excellent Value to your practice/responsibility (if applicable) Very Good Value to your practice/responsibility (if applicable) Good Value to your practice/responsibility (if applicable) Fair Value to your practice/responsibility (if applicable) Poor Value to your practice/responsibility (if applicable) N/A Freedom from commercial bias or influence Freedom from commercial bias or influence Excellent Freedom from commercial bias or influence Very Good Freedom from commercial bias or influence Good Freedom from commercial bias or influence Fair Freedom from commercial bias or influence Poor Freedom from commercial bias or influence N/A Please comment: Question Title * Michael S. Saag, MD: Treating HIV in 2018—Interactive Cases From the Clinic(ians) Excellent Very Good Good Fair Poor N/A Content Content Excellent Content Very Good Content Good Content Fair Content Poor Content N/A Effectiveness of speaker's teaching methods Effectiveness of speaker's teaching methods Excellent Effectiveness of speaker's teaching methods Very Good Effectiveness of speaker's teaching methods Good Effectiveness of speaker's teaching methods Fair Effectiveness of speaker's teaching methods Poor Effectiveness of speaker's teaching methods N/A Value in fulfilling objectives for this presentation Value in fulfilling objectives for this presentation Excellent Value in fulfilling objectives for this presentation Very Good Value in fulfilling objectives for this presentation Good Value in fulfilling objectives for this presentation Fair Value in fulfilling objectives for this presentation Poor Value in fulfilling objectives for this presentation N/A Value to your practice/responsibility (if applicable) Value to your practice/responsibility (if applicable) Excellent Value to your practice/responsibility (if applicable) Very Good Value to your practice/responsibility (if applicable) Good Value to your practice/responsibility (if applicable) Fair Value to your practice/responsibility (if applicable) Poor Value to your practice/responsibility (if applicable) N/A Freedom from commercial bias or influence Freedom from commercial bias or influence Excellent Freedom from commercial bias or influence Very Good Freedom from commercial bias or influence Good Freedom from commercial bias or influence Fair Freedom from commercial bias or influence Poor Freedom from commercial bias or influence N/A Please comment: Question Title * Panelists and Discussion: Treating HIV in 2018—Interactive Cases From the Clinic(ians) Excellent Very Good Good Fair Poor N/A Value of panel members’ contributions to the discussion Value of panel members’ contributions to the discussion Excellent Value of panel members’ contributions to the discussion Very Good Value of panel members’ contributions to the discussion Good Value of panel members’ contributions to the discussion Fair Value of panel members’ contributions to the discussion Poor Value of panel members’ contributions to the discussion N/A Please comment: Question Title * Turner Overton, MD: Cardiovascular Disease Management in HIV Infection Excellent Very Good Good Fair Poor N/A Content Content Excellent Content Very Good Content Good Content Fair Content Poor Content N/A Effectiveness of speaker's teaching methods Effectiveness of speaker's teaching methods Excellent Effectiveness of speaker's teaching methods Very Good Effectiveness of speaker's teaching methods Good Effectiveness of speaker's teaching methods Fair Effectiveness of speaker's teaching methods Poor Effectiveness of speaker's teaching methods N/A Value in fulfilling objectives for this presentation Value in fulfilling objectives for this presentation Excellent Value in fulfilling objectives for this presentation Very Good Value in fulfilling objectives for this presentation Good Value in fulfilling objectives for this presentation Fair Value in fulfilling objectives for this presentation Poor Value in fulfilling objectives for this presentation N/A Value to your practice/responsibility (if applicable) Value to your practice/responsibility (if applicable) Excellent Value to your practice/responsibility (if applicable) Very Good Value to your practice/responsibility (if applicable) Good Value to your practice/responsibility (if applicable) Fair Value to your practice/responsibility (if applicable) Poor Value to your practice/responsibility (if applicable) N/A Freedom from commercial bias or influence Freedom from commercial bias or influence Excellent Freedom from commercial bias or influence Very Good Freedom from commercial bias or influence Good Freedom from commercial bias or influence Fair Freedom from commercial bias or influence Poor Freedom from commercial bias or influence N/A Please comment: Question Title * Raphael J. Landovitz, MD, MSc: Antiretrovirals for HIV Prevention: Optimizing the Use of PrEP and PEP in 2018 Excellent Very Good Good Fair Poor N/A Content Content Excellent Content Very Good Content Good Content Fair Content Poor Content N/A Effectiveness of speaker's teaching methods Effectiveness of speaker's teaching methods Excellent Effectiveness of speaker's teaching methods Very Good Effectiveness of speaker's teaching methods Good Effectiveness of speaker's teaching methods Fair Effectiveness of speaker's teaching methods Poor Effectiveness of speaker's teaching methods N/A Value in fulfilling objectives for this presentation Value in fulfilling objectives for this presentation Excellent Value in fulfilling objectives for this presentation Very Good Value in fulfilling objectives for this presentation Good Value in fulfilling objectives for this presentation Fair Value in fulfilling objectives for this presentation Poor Value in fulfilling objectives for this presentation N/A Value to your practice/responsibility (if applicable) Value to your practice/responsibility (if applicable) Excellent Value to your practice/responsibility (if applicable) Very Good Value to your practice/responsibility (if applicable) Good Value to your practice/responsibility (if applicable) Fair Value to your practice/responsibility (if applicable) Poor Value to your practice/responsibility (if applicable) N/A Freedom from commercial bias or influence Freedom from commercial bias or influence Excellent Freedom from commercial bias or influence Very Good Freedom from commercial bias or influence Good Freedom from commercial bias or influence Fair Freedom from commercial bias or influence Poor Freedom from commercial bias or influence N/A Please comment: Question Title * Tami P. Sullivan, PhD: The Intersection of Intimate Partner Violence and HIV: Detection, Disclosure, and Implications for Treatment Adherence Excellent Very Good Good Fair Poor N/A Content Content Excellent Content Very Good Content Good Content Fair Content Poor Content N/A Effectiveness of speaker's teaching methods Effectiveness of speaker's teaching methods Excellent Effectiveness of speaker's teaching methods Very Good Effectiveness of speaker's teaching methods Good Effectiveness of speaker's teaching methods Fair Effectiveness of speaker's teaching methods Poor Effectiveness of speaker's teaching methods N/A Value in fulfilling objectives for this presentation Value in fulfilling objectives for this presentation Excellent Value in fulfilling objectives for this presentation Very Good Value in fulfilling objectives for this presentation Good Value in fulfilling objectives for this presentation Fair Value in fulfilling objectives for this presentation Poor Value in fulfilling objectives for this presentation N/A Value to your practice/responsibility (if applicable) Value to your practice/responsibility (if applicable) Excellent Value to your practice/responsibility (if applicable) Very Good Value to your practice/responsibility (if applicable) Good Value to your practice/responsibility (if applicable) Fair Value to your practice/responsibility (if applicable) Poor Value to your practice/responsibility (if applicable) N/A Freedom from commercial bias or influence Freedom from commercial bias or influence Excellent Freedom from commercial bias or influence Very Good Freedom from commercial bias or influence Good Freedom from commercial bias or influence Fair Freedom from commercial bias or influence Poor Freedom from commercial bias or influence N/A Please comment: Question Title * Donna C. Futterman, MD: Youth and HIV: Are We on Track to End This Epidemic? Excellent Very Good Good Fair Poor N/A Content Content Excellent Content Very Good Content Good Content Fair Content Poor Content N/A Effectiveness of speaker's teaching methods Effectiveness of speaker's teaching methods Excellent Effectiveness of speaker's teaching methods Very Good Effectiveness of speaker's teaching methods Good Effectiveness of speaker's teaching methods Fair Effectiveness of speaker's teaching methods Poor Effectiveness of speaker's teaching methods N/A Value in fulfilling objectives for this presentation Value in fulfilling objectives for this presentation Excellent Value in fulfilling objectives for this presentation Very Good Value in fulfilling objectives for this presentation Good Value in fulfilling objectives for this presentation Fair Value in fulfilling objectives for this presentation Poor Value in fulfilling objectives for this presentation N/A Value to your practice/responsibility (if applicable) Value to your practice/responsibility (if applicable) Excellent Value to your practice/responsibility (if applicable) Very Good Value to your practice/responsibility (if applicable) Good Value to your practice/responsibility (if applicable) Fair Value to your practice/responsibility (if applicable) Poor Value to your practice/responsibility (if applicable) N/A Freedom from commercial bias or influence Freedom from commercial bias or influence Excellent Freedom from commercial bias or influence Very Good Freedom from commercial bias or influence Good Freedom from commercial bias or influence Fair Freedom from commercial bias or influence Poor Freedom from commercial bias or influence N/A Please comment: Next